KDT is committed to empowering our portfolio companies like Celestial AI to unlock their full potential. That’s why we have established a powerful connection between Koch Labs® and subject matter experts across Koch. From technology to operation, finance and more, our network is able to provide valuable guidance and support to our portfolio companies. By leveraging the knowledge and resources available through Koch Labs, our partners can focus on what they do best - growing their business. Learn how Celestial AI is enabling faster and more efficient communication within computer systems: https://www.celestial.ai/
Koch Disruptive Technologies
Risikokapital- und Private-Equity-Gesellschaften
Wichita, Kansas 13,115 followers
Über uns
Koch Disruptive Technologies (KDT) focuses on partnering with high-growth companies that disrupt current market alternatives with demonstrated technology. KDT looks for opportunities to create mutual benefit by working with principled entrepreneurs who can receive significant value from interacting with Koch companies and whose technology has the potential to transform Koch's core capabilities, create new capabilities, or expand Koch into new platforms.
- Website
-
https://kochdisruptivetechnologies.com/
External link for Koch Disruptive Technologies
- Industrie
- Risikokapital- und Private-Equity-Gesellschaften
- Größe des Unternehmens
- 11-50 Mitarbeiter
- Hauptsitz
- Wichita, Kansas
- Typ
- In Privatbesitz
Standorte
-
Primäre
Wegbeschreibung erhalten
4111 E 37th St N
Wichita, Kansas, US
Employees at Koch Disruptive Technologies
Aktualisierungen
-
Congratulations to the team at Astranis Space Technologies, a KDT portfolio company, on raising a $200 million Series D! Their innovative low-cost telecommunications satellites are set to unlock previously unreachable locations. We’re excited to be a part of Astranis and their mission to connect the world.
Astranis has raised a $200 million Series D, led by a16z Growth Fund and co-led by BAM Elevate. This brings our total capital raised to $750 million, and gets us one step closer to launching 100 MicroGEO satellites by 2030 — and connecting millions to affordable internet. It also fully funds our Omega development program: https://lnkd.in/guRrUXFx Thank you to our participating investors for their support! Andreessen Horowitz, BAM Elevate, BlackRock, Fidelity Investments, Baillie Gifford, Uncorrelated, Y Combinator, Friends & Family Capital, Haystack, Metaplanet, SV Angel, Garage VC, Refactor, PWV/RedwoodJS, Trinity Capital, Jeff Dean, and others.
-
-
At KDT, we believe in the power of collaboration and the mutual benefit it brings. Our partners at Percepto - Autonomous Drones share the advantages of gaining access to our vast network of Koch Industries companies and partners. Through this partnership, Percepto has been able to unlock new growth opportunities and propel its business forward. Discover how Percepto is using robotics and AI to transform industrial site inspections: https://percepto.co/
-
Congratulations to Sidecar Health for their Series D funding success. It’s fantastic to see them shining brightly in Times Square!
Thank you Nasdaq! #SidecarHealth #HealthcareInnovation #SeriesDFunding #SidecarHealth #PriceTransparency #ConsumerEmpowerment
-
-
Congratulations to the entire Sidecar Health team on your Series D! We’re thrilled to lead this round and partner with you on your journey to transform the U.S. health insurance system, making healthcare more accessible and affordable for everyone.
📣 Big News! 📣 We are thrilled to announce that Sidecar Health has secured $165M in Series D financing led by Koch Disruptive Technologies. This is the largest private investment in employer health benefits this year! Our transformative approach to health insurance provides unparalleled price transparency and control, empowering consumers like never before. With this new capital, we’re expanding our employer offering into Florida, building on the success in Ohio and Georgia. Additionally, as part of our partnership with Koch Disruptive Technologies, Sidecar Health will be offered to a subset of Koch Industries employees, marking our entry into the jumbo employer market. Our mission is clear: To make healthcare more accessible and affordable for everyone. By eliminating prior authorizations, network restrictions and referrals, we’re putting the power back in the hands of the consumer. Join us as we reshape the future of healthcare! 🚀 GreatPoint Ventures BOND Cathay Innovation Drive Capital Menlo Ventures Morpheus Ventures #HealthcareInnovation #SeriesDFunding #SidecarHealth #PriceTransparency #ConsumerEmpowerment
-
What does partnering with KDT look like? Hear directly from our partners at Percepto - Autonomous Drones, Celestial AI and Strider Technologies as they share their experiences. Listen as they shed light on the shared principles and entrepreneurial spirit that define our partnerships, driving transformative change in industries. Watch the full testimonial from our partners: https://lnkd.in/g428RtQk
-
Join our partners at Beyond Identity for a panel discussion at #RSAC on May 7th, recognizing veterans in cybersecurity and their transformative contributions to the industry. Don’t miss this opportunity to gain insights and connect with industry leaders.
Join us at #RSAC on May 7th from 5-8pm for a special networking event honoring veterans. Come out to the Intercontinental (steps from Moscone) and hear our panel discussion on the impact of veterans in cybersecurity and the value they bring to the table. Thanks to our sponsors eShare, DemoForce, and VetSec for their support. Grab your spot today! https://hubz.li/Q02t7Kvq0
-
-
Congratulations to our partners at Cellares on their deepened collaboration with Bristol Myers Squibb in advancing the field of CAR-T cell therapies. This expanded partnership represents a major leap forward towards the goal of delivering lifesaving therapies to more patients at lower costs. Terrific work by all involved!
We are thrilled to announce a $380M worldwide capacity reservation and supply agreement with Bristol Myers Squibb for the manufacture of CAR T cell therapies to bring the promise of cell therapies to more patients, faster. To support the production needs of select Bristol Myers Squibb cell therapy assets, Cellares, the world’s first Integrated Development and Manufacturing Organization (IDMO), will allocate the production capacity of multiple Cell Shuttle™ and Cell Q™ systems across its IDMO Smart Factories in the U.S., EU, and Japan. Click here to learn more: https://lnkd.in/gRgXkRB6 #IDMO #CAR-T #CellTherapyManufacturing #CellTherapy #BioTech
Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More Patients, Faster
https://www.cellares.com
-
Yesterday marked a significant moment for Ibotta, Inc., a KDT portfolio company, as they made their debut on the NYSE. Their IPO is a testament to their disruptive vision and ability to create lasting value. Congratulations to the Ibotta team on this momentous achievement!
-
-
Chase Koch recently took the stage at the Global Corporate Venturing & Innovation Summit for a captivating fireside chat, moderated by the talented Maija Palmer. Together, they discussed the beginnings of KDT and our goal to bridge the innovation gap. Chase also highlighted our successes in disrupting existing industries and expanding our footprint into new sectors. Special thanks to Global Corporate Venturing and executive producer Christina Riboldi for putting together an incredible event. Photo credit: Adam Bacher. #GCVISummit #GCVI
-